Table 3. FepABC role in heme acquisition.
Growth halo diameter (mm) | |||||
Strain name | Relevant mutation | 50 µM | 10 µM | 5 µM | 1 µM |
SET 535 | none | 28±2 | 20±2 | 14±2 | 12±2 |
SET 536 | ΔyfeX::Apra | 19±2 | 15±2 | ndg | ndg |
SET 537 | ΔefeUOB::Cm | 19±2 | 13±2 | ndg | ndg |
SET 538 | ΔyfeX::ApraΔefeUOB::Cm | ndg | ndg | ndg | ndg |
SET 538 (pMD1) | ΔyfeX::ApraΔefeUOB::Cm | ndg | ndg | ndg | ndg |
SET 538 (pMD1-fepB) | ΔyfeX::ApraΔefeUOB::Cm | ndg | ndg | ndg | ndg |
SET 538 (pMD1-fepA) | ΔyfeX::ApraΔefeUOB::Cm | ndg | ndg | ndg | ndg |
SET 538 (pMD1-fepAB) | ΔyfeX::ApraΔefeUOB::Cm | 25±2 | 22±2 | 17±2 | 11±2 |
SET 538 (pMD1-fepABC) | ΔyfeX::ApraΔefeUOB::Cm | 23±2 | 22±2 | 17±2 | 11±2 |
SET 538 (pSU19-fepB-6His), | ΔyfeX::ApraΔefeUOB::Cm | ndg | ndg | ndg | ndg |
SET 538 (pSU19-fepB-6His)(pBAD24-fepA) | ΔyfeX::ApraΔefeUOB::Cm | 25±2 | 22±2 | 17±2 | 11±2 |
SET 538 (pMD1-fepAAkiA-B) | ΔyfeX::ApraΔefeUOB::Cm | 25±2 | 22±2 | 17±2 | 11±2 |
SET 538 (pBAD24-efeB) | ΔyfeX::ApraΔefeUOB::Cm | 17±2 | 15±2 | ndg | ndg |
SET 538 (pBAD24-efeB)(pDIA561-efeO) | ΔyfeX::ApraΔefeUOB::Cm | 20±2 | 19±2 | 17±2 | 14±2 |
SET 538 (pMD1-fepB)(pDIA561-efeO) | ΔyfeX::ApraΔefeUOB::Cm | ndg | ndg | ndg | ndg |
SET 539 (pMD1-fepAB) | ΔefeUOB::CmΔdppF::Km | ndg | ndg | ndg | ndg |
SET 539(pMD1- fepABC) | ΔefeUOB::CmΔdppF::Km | ndg | ndg | ndg | ndg |
(a) ndg: no detectable growth around wells.
Names of strains and plasmid-borne complementing genes carried on pDIA561, pBAD24 and pMD1 are indicated in the first column. Aliquots of 50 µl of bovine hemoglobin at various concentrations calculated on the basis of the heme monomer were provided in wells punched into solidified agar. Plates were incubated for 48 h at 37°C and the growth halo diameter in mm around the wells was measured. All experiments were repeated three times.